Yuka Iijima‐Yamashita

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation

Tetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta et al. · Blood · 2017 · 343 citations · Full text

Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasms

Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya et al. · Blood · 2022 · 132 citations · Full text

Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia

Hiroo Ueno, Kenichi Yoshida, Yusuke Shiozawa et al. · Blood Advances · 2020 · 54 citations · Full text

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of <i>CDX2</i> and <i>IDH1/2</i> mutations

Takahiko Yasuda, Masashi Sanada, Masahito Kawazu et al. · Blood · 2021 · 49 citations · Full text

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study

Akira Shimada, Yuka Iijima‐Yamashita, Akio Tawa et al. · International Journal of Hematology · 2018 · 37 citations

Hematological Malignancy, Oncology, Risk-stratified Therapy +9